Niels‐Erik Viby

731 total citations
5 papers, 264 citations indexed

About

Niels‐Erik Viby is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Niels‐Erik Viby has authored 5 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 2 papers in Surgery and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Niels‐Erik Viby's work include Pancreatic function and diabetes (2 papers), Diabetes Treatment and Management (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Niels‐Erik Viby is often cited by papers focused on Pancreatic function and diabetes (2 papers), Diabetes Treatment and Management (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Niels‐Erik Viby collaborates with scholars based in Denmark. Niels‐Erik Viby's co-authors include Steen Seier Poulsen, Hannelouise Kissow, Bolette Hartmann, Jens J. Holst, Marie S. Isidor, Jacob B. Hansen, Kristine Juul Hare, L. Hansen, Lars Thim and Mette M. Rosenkilde and has published in prestigious journals such as Endocrinology, Digestive Diseases and Sciences and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Niels‐Erik Viby

5 papers receiving 261 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Niels‐Erik Viby Denmark	5	130	97	67	63	55	5	264
Kaori Koyama Japan	10	107 0.8×	106 1.1×	122 1.8×	57 0.9×	44 0.8×	19	326
Yung-Ching Ming Taiwan	8	43 0.3×	40 0.4×	172 2.6×	54 0.9×	16 0.3×	22	291
Cédric Peleman Belgium	7	25 0.2×	77 0.8×	40 0.6×	103 1.6×	27 0.5×	11	280
Kerstin Dobberstein Germany	4	87 0.7×	36 0.4×	118 1.8×	71 1.1×	35 0.6×	6	431
Kanokphong Suparan Thailand	10	34 0.3×	28 0.3×	50 0.7×	75 1.2×	57 1.0×	28	316
Nóra Fanni Bánki Hungary	8	58 0.4×	20 0.2×	56 0.8×	113 1.8×	8 0.1×	11	286
H Narbonne France	10	96 0.7×	37 0.4×	34 0.5×	384 6.1×	39 0.7×	15	563
Stanley W. Ashley United States	11	28 0.2×	77 0.8×	363 5.4×	57 0.9×	177 3.2×	13	481
T Bozkurt Germany	11	39 0.3×	62 0.6×	278 4.1×	22 0.3×	119 2.2×	27	403
Niall Dempster United Kingdom	7	60 0.5×	24 0.2×	136 2.0×	75 1.2×	12 0.2×	15	301

Countries citing papers authored by Niels‐Erik Viby

Since Specialization

Citations

This map shows the geographic impact of Niels‐Erik Viby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niels‐Erik Viby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niels‐Erik Viby more than expected).

Fields of papers citing papers by Niels‐Erik Viby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niels‐Erik Viby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niels‐Erik Viby. The network helps show where Niels‐Erik Viby may publish in the future.

Co-authorship network of co-authors of Niels‐Erik Viby

This figure shows the co-authorship network connecting the top 25 collaborators of Niels‐Erik Viby. A scholar is included among the top collaborators of Niels‐Erik Viby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niels‐Erik Viby. Niels‐Erik Viby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Viby, Niels‐Erik, Lars Pedersen, Thomas Kromann Lund, et al.. (2014). Trefoil factor peptides in serum and sputum from subjects with asthma and COPD. The Clinical Respiratory Journal. 9(3). 322–329. 11 indexed citations

2.

Viby, Niels‐Erik, et al.. (2013). Glucagon-Like Peptide-1 (GLP-1) Reduces Mortality and Improves Lung Function in a Model of Experimental Obstructive Lung Disease in Female Mice. Endocrinology. 154(12). 4503–4511. 105 indexed citations

3.

Kissow, Hannelouise, Niels‐Erik Viby, Bolette Hartmann, et al.. (2012). Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine. Cancer Chemotherapy and Pharmacology. 70(1). 39–48. 37 indexed citations

4.

Kissow, Hannelouise, Bolette Hartmann, Jens J. Holst, et al.. (2012). Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice. Regulatory Peptides. 179(1-3). 91–100. 84 indexed citations

5.

Rasmussen, Andreas Rosén, Niels‐Erik Viby, Kristine Juul Hare, et al.. (2010). The Intestinotrophic Peptide, GLP-2, Counteracts the Gastrointestinal Atrophy in Mice Induced by the Epidermal Growth Factor Receptor Inhibitor, Erlotinib, and Cisplatin. Digestive Diseases and Sciences. 55(10). 2785–2796. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact